https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct06391775-2026-08-11 Hipa.ai en 2026-08-11T00:00:00.000Z Pembrolizumab trial posts safety data in solid tumors https://hipa.ai/drug/atezolizumab/updates/trial-results-posted-nct03600701-2026-08-11 Hipa.ai en 2026-08-11T00:00:00.000Z Atezolizumab-cobimetinib trial posts results in lung cancer https://hipa.ai/drug/empagliflozin/updates/trial-results-posted-nct05236673-2026-08-10 Hipa.ai en 2026-08-10T00:00:00.000Z Empagliflozin PMS in Korean heart failure patients posted https://hipa.ai/drug/semaglutide/updates/trial-results-posted-nct05035082-2026-08-10 Hipa.ai en 2026-08-10T00:00:00.000Z Semaglutide lowers HbA1c vs other oral diabetes pills https://hipa.ai/drug/tofacitinib/updates/boxed-warning-present-label-tofacitinib-label-effective-2026-2026-08-10 Hipa.ai en 2026-08-10T00:00:00.000Z Tofacitinib label adds boxed warning for serious risks https://hipa.ai/drug/atezolizumab/updates/trial-results-posted-nct04729959-2026-08-07 Hipa.ai en 2026-08-07T00:00:00.000Z Atezolizumab trial posts recurrent glioblastoma results https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct05010629-2026-08-07 Hipa.ai en 2026-08-07T00:00:00.000Z Pembrolizumab trial posts results in salivary gland cancer https://hipa.ai/drug/atezolizumab/updates/trial-results-posted-nct05243862-2026-08-07 Hipa.ai en 2026-08-07T00:00:00.000Z Atezolizumab combo trial posts colorectal cancer results https://hipa.ai/drug/tofacitinib/updates/boxed-warning-present-label-tofacitinib-label-effective-2026-2026-08-07 Hipa.ai en 2026-08-07T00:00:00.000Z Tofacitinib carries boxed warning on label effective 2026-08-07 https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct03991130-2026-08-06 Hipa.ai en 2026-08-06T00:00:00.000Z Nivolumab phase 2 melanoma and RCC trial posts results https://hipa.ai/drug/tofacitinib/updates/boxed-warning-present-label-tofacitinib-label-effective-2026-2026-08-06 Hipa.ai en 2026-08-06T00:00:00.000Z Tofacitinib label carries boxed warning effective Aug. 6, 2026 https://hipa.ai/drug/baxdrostat/updates/trial-results-posted-nct06168409-2026-08-06 Hipa.ai en 2026-08-06T00:00:00.000Z Baxdrostat lowers 24-hour SBP in resistant hypertension trial